X T L Biopharmaceuticals reported $2.21M in Current Liabilities for its fiscal quarter ending in December of 2024.





Current Liabilities Change Date
Alaunos Therapeutics USD 921K 153K Sep/2025
Bioline Rx USD 13.67M 1.81M Sep/2025
Teva Pharmaceutical Industries USD 13.46B 1.96B Dec/2025
X T L Biopharmaceuticals USD 2.21M 260K Dec/2024